ATE431850T1 - Verfahren zur untersuchung von krankheiten des zentralen nervensystems und verfahren zum aufsuchen von arzneimitteln - Google Patents

Verfahren zur untersuchung von krankheiten des zentralen nervensystems und verfahren zum aufsuchen von arzneimitteln

Info

Publication number
ATE431850T1
ATE431850T1 AT99921185T AT99921185T ATE431850T1 AT E431850 T1 ATE431850 T1 AT E431850T1 AT 99921185 T AT99921185 T AT 99921185T AT 99921185 T AT99921185 T AT 99921185T AT E431850 T1 ATE431850 T1 AT E431850T1
Authority
AT
Austria
Prior art keywords
nervous system
central nervous
medicinal products
studying diseases
selecting medicinal
Prior art date
Application number
AT99921185T
Other languages
English (en)
Inventor
Tsutomu Takagi
Naoya Sato
Masaya Tohyama
Original Assignee
Mitsubishi Tanabe Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tanabe Pharma Corp filed Critical Mitsubishi Tanabe Pharma Corp
Application granted granted Critical
Publication of ATE431850T1 publication Critical patent/ATE431850T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711Alzheimer's disease; Amyloid plaque core protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT99921185T 1998-05-21 1999-05-20 Verfahren zur untersuchung von krankheiten des zentralen nervensystems und verfahren zum aufsuchen von arzneimitteln ATE431850T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13940898 1998-05-21
PCT/JP1999/002627 WO1999060122A1 (en) 1998-05-21 1999-05-20 Method for examining central nervous system diseases and method for screening remedies

Publications (1)

Publication Number Publication Date
ATE431850T1 true ATE431850T1 (de) 2009-06-15

Family

ID=15244561

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99921185T ATE431850T1 (de) 1998-05-21 1999-05-20 Verfahren zur untersuchung von krankheiten des zentralen nervensystems und verfahren zum aufsuchen von arzneimitteln

Country Status (6)

Country Link
US (2) US6579679B1 (de)
EP (1) EP1078987B1 (de)
AT (1) ATE431850T1 (de)
AU (1) AU3849499A (de)
DE (1) DE69940906D1 (de)
WO (1) WO1999060122A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003012548A (ja) * 2001-06-27 2003-01-15 Japan Science & Technology Corp 医薬組成物
JP2003018991A (ja) 2001-06-27 2003-01-21 Japan Science & Technology Corp プレセニリン−2遺伝子エキソン5欠損型スプライシング異常の生成に関与する核酸
US7358063B2 (en) * 2001-07-19 2008-04-15 Sysmex Corporation Method of detecting PS2V
US7610305B2 (en) 2003-04-24 2009-10-27 Sun Microsystems, Inc. Simultaneous global transaction and local transaction management in an application server
US7739252B2 (en) * 2003-07-14 2010-06-15 Oracle America, Inc. Read/write lock transaction manager freezing
US8521875B2 (en) * 2003-09-04 2013-08-27 Oracle America, Inc. Identity for data sources
US20070087376A1 (en) * 2004-08-30 2007-04-19 Potashkin Judith A Splice variants of pre-mRNA transcripts as biomarkers in idiopathic neurodegenerative diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5986054A (en) * 1995-04-28 1999-11-16 The Hospital For Sick Children, Hsc Research And Development Limited Partnership Genetic sequences and proteins related to alzheimer's disease
JP2002515740A (ja) * 1996-04-04 2002-05-28 ユニバーシティ・オブ・サウス・フロリダ プレセニリン−2遺伝子の変種

Also Published As

Publication number Publication date
DE69940906D1 (de) 2009-07-02
US20040002100A1 (en) 2004-01-01
US6579679B1 (en) 2003-06-17
EP1078987A1 (de) 2001-02-28
EP1078987B1 (de) 2009-05-20
EP1078987A4 (de) 2003-10-01
AU3849499A (en) 1999-12-06
WO1999060122A1 (en) 1999-11-25

Similar Documents

Publication Publication Date Title
ATE360808T1 (de) Unabhängiges gerät zur extraktion, amplifikation und nachweis von nukleinsäuren
GB2383043A (en) Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human brain
EP1885238A4 (de) Verfahren und vorrichtung für schnelle interpretative analyse von elektrokardiogramm-wellenformen
DE69223848D1 (de) Biosensor und Verfahren zur quantitativen Analyse
DE69222272D1 (de) Biosensor und Verfahren zur quantitativen Analyse
DE602005013670D1 (de) Zusammensetzungen und verfahren zur quantifizierung von serumglykoproteinen
DE69831917D1 (de) Verbessertes Verfahren und Vorrichtung zur Waferprobendetektion
DE59609524D1 (de) Verfahren zur Genexpressionsanalyse
DE10083909T1 (de) Vorrichtung und Verfahren zur Analyse von Mehrkanalbauteilen sowie zugehöriges Kalibrierungsverfahren
DE69805756D1 (de) Verfahren und vorrichtung zur analyse
DE69636967D1 (de) Verfahren zur Analyse mittels Lichtstreuung
EP1123130A4 (de) Vorrichtung und verfahren zur diagnose und therapie von elektrophysiologischen krankheiten
DE60040335D1 (de) Derivatisierte nukleinsäuren und deren verwendung
DE69937910D1 (de) Gerät und Verfahren zur Probenuntersuchung mittels Ladungsträgerstrahlen
DE60103180D1 (de) Verfahren und vorrichtung zur überkritischen nassoxidation von stoffen
DE60326527D1 (de) Verfahren und Gerät zur Ultraschallkontrastbildformung unter Benutzung von gestuften Chirp-Wellenformen
DE69926851D1 (de) Verfahren und Vorrichtung zur Sprachaktivitätsdetektion
DE69837503D1 (de) Vorrichtung und Verfahren zur Prüfung von optischen Anordnungen
DE602004026767D1 (de) Immunsorbens-bluttests zur beurteilung von paroxysmalen zerebralentladungen
EP0975946A4 (de) Automatisiertes verfahren und vorrichtung zur auswertung der betriebsparameter von endoskopen
ATE431850T1 (de) Verfahren zur untersuchung von krankheiten des zentralen nervensystems und verfahren zum aufsuchen von arzneimitteln
DE69628898D1 (de) Vorrichtung zur ausseraxialen Prüfung von anisotropen Materialien
DE69807806D1 (de) Verfahren und vorrichtung zur kodierung eines audiosignals mittels "vorwärts"- und "rückwärts"-lpc-analyse
EP1672062A4 (de) Verfahren und kit zum nachweis von sklerose verursachenden proliferativen erkrankungen und/oder heilmittel gegen sklerose verursachende proliferative erkrankungen sowie verfahren und kit zur identifizierung einer bei der vorbeugung und/oder behandlung von sklerose verursachenden proliferativen erkrankungen wirksamen substanz
DE69819227D1 (de) Vorrichtung und Verfahren zur Trübungsmessung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties